Skip to main content
SpringerLink
Log in

Does ACE inhibitor therapy delay onset and progression of cardiac dysfunction in duchenne muscular dystrophy?

  • Clinical Trials Report
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hoffman EP: Dystrophinopathies. In The Molecular and Genetic Basis of Neurologic and Psychiatric Disease. Edited by Rosenberg RN, Prusiner SB, DiMauro S, et al. Philadelphia: Butterworth-Heinemann; 2003:467–479.

    Google Scholar 

  2. Moxley RT 3rd, Ashwal S, Pandya S, et al.: Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2005, 64:13–20.

    PubMed  CAS  Google Scholar 

  3. Eagle M, Baudouin SV, Chandler C, et al.: Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002, 12:926–929.

    Article  PubMed  Google Scholar 

  4. Finder JD, Birnkrant D, Carl J, et al.: Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 2004, 170:456–465.

    Article  PubMed  Google Scholar 

  5. Nigro G, Comi LI, Politano L, Bain RJ: The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 1990, 26:271–277.

    Article  PubMed  CAS  Google Scholar 

  6. Finsterer J, Stollberger C: The heart in human dystrophinopathies. Cardiology 2003, 99:1–19.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Michio Hirano MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hirano, M. Does ACE inhibitor therapy delay onset and progression of cardiac dysfunction in duchenne muscular dystrophy?. Curr Neurol Neurosci Rep 6, 35–36 (2006). https://doi.org/10.1007/s11910-996-0007-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-996-0007-x

Keywords

Search

Navigation